Focus on Bridging Treatment Gaps

At Strongbridge Biopharma, our focus on rare diseases has resulted in a portfolio of innovative treatments for rare neuromuscular and endocrine conditions, including the commercialization of KEVEYIS in the U.S.

Committed to Positive Results

At Strongbridge Biopharma, we are committed to delivering better results for patients, healthcare providers, employees, and investors.

Passion for Compassion

You are leaving this site

You are about to leave strongbridgebio.com. The link will take you to a website that may be maintained by a third party, which is solely responsible for its content. Strongbridge provides this link as a service to its web visitors, and is not responsible for the privacy policy or terms of use of any third-party website.